The Impact of Clinical Trials on Kidney Cancer Treatment and the Restratification of Metastatic RCC

This chapter explores the S-track trial and the keynote 564 trial, both of which have significant implications for adjuvant treatment of kidney cancer. The discussion also covers the use of tools like MSKCC and IMDC criteria to restratify metastatic kidney cancer.